FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “MAPS VACCINE”, which is offered here for Vaccines; vaccines for the prophylaxis and treatment of infectious diseases and cancer; vaccines, immuno-therapies for the treatment of infectious diseases and cancer; vaccines comprising polysaccharide antigens and protein-based antigens; vaccines, immuno- therapies comprising polysaccharide antigens and protein-based antigens;vaccine;research and development services in the field of vaccines; research and development services in the field of vaccines for the prophylaxis and treatment of infectious diseases and cancer; research and development services in the field of vaccines, immuno-therapies for the treatment of infectious diseases and cancer; research and development in the field of vaccines comprising polysaccharide antigens and protein- based antigens; research and development in the field of vaccines, immuno-therapies comprising polysaccharide antigens and protein- based antigens;.
Its status is currently believed to be active. Its class is unavailable. “MAPS VACCINE” is believed to be currently owned by “Affinivax, Inc.”
| Owner: |
AFFINIVAX, INC.
Owner Details |
|---|---|
| Description: |
Vaccines; vaccines for the prophylaxis and treatment of infectious diseases and cancer; vaccines, immuno-therapies for the treatment of infectious diseases and cancer; vaccines comprising polysaccharide antigens and protein-based antigens; vaccines, immuno- therapies comprising polysaccharide antigens and protein-based antigens;VACCINE;Research and development services in the field of vaccines; research and development services in the field of vaccines for the prophylaxis and treatment of infectious diseases and cancer; research and development services in the field of vaccines, immuno-therapies for the treatment of infectious diseases and cancer; research and development in the field of vaccines comprising polysaccharide antigens and protein- based antigens; research and development in the field of vaccines, immuno-therapies comprising polysaccharide antigens and protein- based antigens;
|
| Categories: | VACCINES |